Bintrafusp alfa (anti-PD-L1/TGFβ Trap)

DRUG2 trials

Sponsors

Amsterdam UMC, Institut Bergonie

Conditions

Adult patients with locally advanced/unresectable and/or metastatic soft-tissue sarcomas.Esophageal squamous cell carcinoma

Phase 2

TGF-β And PDL-1 inhibition with Bintrafusp alfa in Esophageal Squamous Cell carcinoma combined with chemoradiation TheRapY (TAPESTRY)

Active, not recruitingCTIS2023-503312-32-00

Amsterdam UMCEsophageal squamous cell carcinoma

Start: 2024-06-24Target: 67Updated: 2024-06-24

TRUST : BINTRAFUSP ALFA AND DOXORUBICIN HYDROCHLORIDE IN TREATING PATIENTS WITH ADVANCED SARCOMA

Active, not recruitingCTIS2023-509497-30-00

Institut BergonieAdult patients with locally advanced/unresectable and/or metastatic soft-tissue sarcomas.

Start: 2022-02-21Target: 80Updated: 2025-12-12